Viva Biotech Holdings (VBIZF)
USD 0.23
(-24.16%)
USD 0.23
(-24.16%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 738.43 Million CNY | -9.47% |
| 2022 | 815.67 Million CNY | 25.3% |
| 2021 | 650.98 Million CNY | 113.53% |
| 2020 | 304.86 Million CNY | 95.59% |
| 2019 | 155.87 Million CNY | 47.81% |
| 2018 | 105.45 Million CNY | 22.36% |
| 2017 | 86.18 Million CNY | 59.19% |
| 2016 | 54.14 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 23.33 Million USD | 0.0% |
| 2024 Q1 | 23.48 Million USD | -48.93% |
| 2023 FY | 738.43 Million CNY | -9.47% |
| 2023 Q1 | 29.55 Million USD | -56.28% |
| 2023 Q2 | 58.57 Million USD | 98.17% |
| 2023 Q3 | 22.76 Million USD | -61.13% |
| 2023 Q4 | 45.98 Million USD | 101.97% |
| 2022 FY | 815.67 Million CNY | 25.3% |
| 2022 Q4 | 67.61 Million USD | 104.39% |
| 2022 Q3 | 33.07 Million USD | -37.67% |
| 2022 Q2 | 53.07 Million USD | 0.0% |
| 2021 Q4 | 51.94 Million USD | 0.0% |
| 2021 FY | 650.98 Million CNY | 113.53% |
| 2021 Q2 | 48.86 Million USD | 0.0% |
| 2020 Q2 | 14.25 Million USD | 0.0% |
| 2020 Q4 | 30.21 Million USD | 0.0% |
| 2020 FY | 304.86 Million CNY | 95.59% |
| 2019 Q2 | 10.63 Million USD | 0.0% |
| 2019 Q4 | 12 Million USD | 0.0% |
| 2019 FY | 155.87 Million CNY | 47.81% |
| 2018 FY | 105.45 Million CNY | 22.36% |
| 2017 FY | 86.18 Million CNY | 59.19% |
| 2016 FY | 54.14 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 9.61 Million USD | -7583.196% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 594406.686% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -519.971% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 231216.063% |
| Qrons Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 1530243.6% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | 30276114.76% |
| BioStem Technologies, Inc. | 15.42 Million USD | -4687.289% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -418132.895% |
| CSL Limited | 7.56 Billion USD | 90.234% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 2962.361% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -6208.15% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -525474.377% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -4823.208% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -23804929.014% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -7439.637% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -1123366.407% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 2162419.18% |
| Mesoblast Limited | -35.16 Million USD | 2199.727% |
| Marizyme, Inc. | 457.7 Thousand USD | -161234.668% |
| Genus plc | 178.7 Million USD | -313.224% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | -235.492% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -1186593.665% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -179932.914% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 6713118.182% |
| ContraFect Corporation | -154 Thousand USD | 479601.299% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 1476964.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -961888.51% |
| IMV Inc. | -962.29 Thousand USD | 76836.312% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 190662.605% |
| MultiCell Technologies, Inc. | 49.32 USD | -1497226177.372% |
| ONE Bio Corp. | 20.12 Million USD | -3569.147% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -1733.93% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -1509985.89% |
| Q BioMed Inc. | -8988.00 USD | 8215854.339% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -2513.456% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 4787651.867% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -1564.717% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 64785.539% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -1054802.857% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 14911893.215% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 757349.654% |
| GB Sciences, Inc. | -624.00 USD | 118338561.538% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 858462.394% |
| HST Global, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 355015484.615% |
| Enzolytics Inc. | 30.7 Thousand USD | -2404589.332% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -152964.156% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 33.383% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 143621.409% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -119506.598% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | -80.302% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 8338311.382% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 880768.821% |
| Kadimastem Ltd | -630.13 Thousand USD | 117285.759% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -74641.518% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 6239491.635% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -418132.895% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -54310.773% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 2546417.241% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -163980.321% |
| SYBLEU INC | 11.69 Thousand USD | -6313443.092% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -15925.0% |
| Bioxytran, Inc. | -8285.00 USD | 8912978.696% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 198071.046% |
| Neutra Corp. | 14.33 Thousand USD | -5151152.18% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 900626.829% |
| PureTech Health plc | -1.6 Million USD | 46165.627% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 73852.042% |
| IXICO plc | 3.27 Million USD | -22482.018% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 106502.305% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 41330.151% |
| CSL Limited | 7.7 Billion USD | 90.416% |
| Cellectis S.A. | 18 Thousand USD | -4102300.0% |